Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Hazzan

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Nephrologie & Therapeutique|November 2, 2023
[Immune modulation with extracorporeal photopheresis in renal transplantation: proof of concept clinical outcomes and perspective]Thomas Crépin, Arnaud Lionet, Jean-François Augusto, et al.
Medicine|December 27, 2019
Description of a transient proximal tubulopathy induced by amino acids perfusion in peptide receptor radionuclide therapy: A case reportRémi Lenain, Aghilès Hamroun, Georges Lion, et al.
Journal of Epidemiology and Population Health|January 23, 2025
Evaluating script concordance tests (SCTs) through the lens of Bayesian reasoning: Enhancing assessment in medical educationLuc Dauchet, Raphaël Bentegeac, Haress Ghauss, et al.
Journal of the American Society of Nephrology : JASN|July 1, 2005
Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trialMarc Hazzan, Myriam Labalette, Marie Christine Copin, et al.
Journal of the American Society of Nephrology : JASN|July 2, 2011
Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipientsMarc Hazzan, Alexandre Hertig, David Buob, et al.
BMC Medical Education|March 28, 2025
Motivational factors influencing the choice of oncology as a specialty among French medical studentsNicolas Penel, Pierre-Yves Cren, Christophe Ducroq, et al.
Medicine|June 23, 2017
Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma: A case reportMehdi Maanaoui, Camille Saint-Jacques, Viviane Gnemmi, et al.
Transplantation|February 29, 2020
External Validation of the DynPG for Kidney Transplant RecipientsRémi Lenain, Etienne Dantan, Magali Giral, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 19, 2022
Impact of kidney transplantation in obese candidates: a time-dependent propensity score matching studyChristel Castelli, Yohann Foucher, Julie Boucquemont, et al.
Transplantation|September 14, 2006
Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trialMarc Hazzan, David Buob, Myriam Labalette, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Nephrologie & Therapeutique|November 2, 2023
[Immune modulation with extracorporeal photopheresis in renal transplantation: proof of concept clinical outcomes and perspective]Thomas Crépin, Arnaud Lionet, Jean-François Augusto, et al.
Medicine|December 27, 2019
Description of a transient proximal tubulopathy induced by amino acids perfusion in peptide receptor radionuclide therapy: A case reportRémi Lenain, Aghilès Hamroun, Georges Lion, et al.
Journal of Epidemiology and Population Health|January 23, 2025
Evaluating script concordance tests (SCTs) through the lens of Bayesian reasoning: Enhancing assessment in medical educationLuc Dauchet, Raphaël Bentegeac, Haress Ghauss, et al.
Journal of the American Society of Nephrology : JASN|July 1, 2005
Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trialMarc Hazzan, Myriam Labalette, Marie Christine Copin, et al.
Journal of the American Society of Nephrology : JASN|July 2, 2011
Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipientsMarc Hazzan, Alexandre Hertig, David Buob, et al.
BMC Medical Education|March 28, 2025
Motivational factors influencing the choice of oncology as a specialty among French medical studentsNicolas Penel, Pierre-Yves Cren, Christophe Ducroq, et al.
Medicine|June 23, 2017
Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma: A case reportMehdi Maanaoui, Camille Saint-Jacques, Viviane Gnemmi, et al.
Transplantation|February 29, 2020
External Validation of the DynPG for Kidney Transplant RecipientsRémi Lenain, Etienne Dantan, Magali Giral, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 19, 2022
Impact of kidney transplantation in obese candidates: a time-dependent propensity score matching studyChristel Castelli, Yohann Foucher, Julie Boucquemont, et al.
Transplantation|September 14, 2006
Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trialMarc Hazzan, David Buob, Myriam Labalette, et al.
Pageof 12